Ganesha, I dont have a single link to show that Dr
Post# of 63846
(Total Views: 400)
Posted On: 10/15/2020 8:20:50 PM
Ganesha, I dont have a single link to show that Dr. Seethamraju bulldozed the FDA into approving LL despite an absence of clinical studies and also despite the FDA scientists' belief that leronlimab had no application to leronlimab.
i don't think that there exists a single document or interview which relates all of the details.
At least twicein interviews or conference calls, Pourhassan has explained that Cytodyn requested to use leronlimab on covid patients way back in March and the FDA said "No, you have to do some preclinical studies."
So the FDA categorically denied Cytodyn's request to try leronlimab on covid.
Without a doubt, there are no preclinical leronlimab studies for covid. They do not exist. And that is the basis for the FDA's denial to try LL in covid.
Enter Dr. Seethamraju. At least three times in conference calls or interview, Pourhassan explained that Dr. Seethamraju solicited the FDA to use LL on two of his terminal patients. Dr. Seethamraju's FDA solicitation occurred after the FDA had already declined Cytodyn's request to try LL in covid.
Somehow or other, Dr. Seethamraju prevailed in his solicitation of the FDA, and the FDA agreed to let Dr. Seethamraju try LL on two terminal covid patients.
A key question that has never been answered, maybe even never asked, is:
Why was Dr. Seethamraju able to prevail at the FDA where Cytodyn could not? Of course Dr. Seethamraju was watching his patients die, so there is that.
When the first two patients responded postively to lernlimab, the EIND floodgates opened for LL.
This story, told several times by Pourhassan, is why Pourhassan calls Seethamraju the "hero doctor".
Also told in the story at least twice by Pourhassan is the part that the FDA did not believe leronlimab would do anything for covid. There was no mechanism of action.
Its not surprising that the FDA scientists believed LL had no application to covid because at that time, Patterson's preprint was obviously not published. Patterson and others must have had the idea, but it was just an idea and a pretty new one at that. RANTES signalling as a contribution to covid deaths was not widely known, let alone believed, by many people.
Perhaps Dr. Bruce Patterson played some sort of key role supporting Dr. Seethamraju's solicitaion of the FDA, but the way Seethamraju is going it looks like he may not need help from anyone
A google search for " seethamraju 'hero doctor' " gets a few hits so you might be able to start there.
i don't think that there exists a single document or interview which relates all of the details.
At least twicein interviews or conference calls, Pourhassan has explained that Cytodyn requested to use leronlimab on covid patients way back in March and the FDA said "No, you have to do some preclinical studies."
So the FDA categorically denied Cytodyn's request to try leronlimab on covid.
Without a doubt, there are no preclinical leronlimab studies for covid. They do not exist. And that is the basis for the FDA's denial to try LL in covid.
Enter Dr. Seethamraju. At least three times in conference calls or interview, Pourhassan explained that Dr. Seethamraju solicited the FDA to use LL on two of his terminal patients. Dr. Seethamraju's FDA solicitation occurred after the FDA had already declined Cytodyn's request to try LL in covid.
Somehow or other, Dr. Seethamraju prevailed in his solicitation of the FDA, and the FDA agreed to let Dr. Seethamraju try LL on two terminal covid patients.
A key question that has never been answered, maybe even never asked, is:
Why was Dr. Seethamraju able to prevail at the FDA where Cytodyn could not? Of course Dr. Seethamraju was watching his patients die, so there is that.
When the first two patients responded postively to lernlimab, the EIND floodgates opened for LL.
This story, told several times by Pourhassan, is why Pourhassan calls Seethamraju the "hero doctor".
Also told in the story at least twice by Pourhassan is the part that the FDA did not believe leronlimab would do anything for covid. There was no mechanism of action.
Its not surprising that the FDA scientists believed LL had no application to covid because at that time, Patterson's preprint was obviously not published. Patterson and others must have had the idea, but it was just an idea and a pretty new one at that. RANTES signalling as a contribution to covid deaths was not widely known, let alone believed, by many people.
Perhaps Dr. Bruce Patterson played some sort of key role supporting Dr. Seethamraju's solicitaion of the FDA, but the way Seethamraju is going it looks like he may not need help from anyone
A google search for " seethamraju 'hero doctor' " gets a few hits so you might be able to start there.
(9)
(0)